49 results
8-K
RVNC
Revance Therapeutics Inc
13 Feb 24
Departure of Directors or Certain Officers
4:28pm
include (i) achievement of specified total revenue targets for DAXXIFY® and the RHA® Collection of dermal fillers combined (80% weighting); (ii
8-K
t40eb9bp39jgrnijbq
7 Feb 22
Departure of Directors or Certain Officers
4:03pm
PRE 14A
68jpust 05q66v24s
12 Mar 21
Preliminary proxy
4:13pm
8-K
bwuwea4rru2mr035uwy
27 Jan 21
Departure of Directors or Certain Officers
12:00am
424B3
kr30zzy3xjp
24 Jun 20
Prospectus supplement
5:18pm
S-4/A
hr4tn7a
23 Jun 20
Registration of securities issued in business combination transactions (amended)
6:09am